Cargando…
Understanding Laboratory Testing for SARS-CoV-2
The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinica...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145134/ https://www.ncbi.nlm.nih.gov/pubmed/33946855 http://dx.doi.org/10.3390/children8050355 |
_version_ | 1783697105717559296 |
---|---|
author | Cheema, Ritu Blumberg, Dean A. |
author_facet | Cheema, Ritu Blumberg, Dean A. |
author_sort | Cheema, Ritu |
collection | PubMed |
description | The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinical diagnosis and making therapeutic decisions but also play an important role in the understanding of the epidemiology of the pandemic. There is limited experience with currently available tests and differences may exist among tests even using similar technology. The focus of this review is to improve clinicians’ understanding of SARS-CoV-2 test procedures including their limitations. We discuss the impact of different host and environmental factors on test results. |
format | Online Article Text |
id | pubmed-8145134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81451342021-05-26 Understanding Laboratory Testing for SARS-CoV-2 Cheema, Ritu Blumberg, Dean A. Children (Basel) Opinion The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinical diagnosis and making therapeutic decisions but also play an important role in the understanding of the epidemiology of the pandemic. There is limited experience with currently available tests and differences may exist among tests even using similar technology. The focus of this review is to improve clinicians’ understanding of SARS-CoV-2 test procedures including their limitations. We discuss the impact of different host and environmental factors on test results. MDPI 2021-04-29 /pmc/articles/PMC8145134/ /pubmed/33946855 http://dx.doi.org/10.3390/children8050355 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Opinion Cheema, Ritu Blumberg, Dean A. Understanding Laboratory Testing for SARS-CoV-2 |
title | Understanding Laboratory Testing for SARS-CoV-2 |
title_full | Understanding Laboratory Testing for SARS-CoV-2 |
title_fullStr | Understanding Laboratory Testing for SARS-CoV-2 |
title_full_unstemmed | Understanding Laboratory Testing for SARS-CoV-2 |
title_short | Understanding Laboratory Testing for SARS-CoV-2 |
title_sort | understanding laboratory testing for sars-cov-2 |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145134/ https://www.ncbi.nlm.nih.gov/pubmed/33946855 http://dx.doi.org/10.3390/children8050355 |
work_keys_str_mv | AT cheemaritu understandinglaboratorytestingforsarscov2 AT blumbergdeana understandinglaboratorytestingforsarscov2 |